SCHEMBL9433429

SCHEMBL9433429

CS(=O)(=O)NC(=O)CCc1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 9/20 0.68
FBP1 P09467 1/20 0.68
GRIN1 Q05586 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9432682 0.86 GRIN1 (0.71) GPR17FBP1GRIN1
SCHEMBL30559677 0.81 GPR17 (1.00) GPR17FBP1GRIN1
SCHEMBL8463078 0.81 GPR17 (1.00) GPR17FBP1GRIN1
SCHEMBL9433912 0.80 GRIN1 (0.68) GPR17FBP1GRIN1
SCHEMBL266498 0.76 GPR17 (0.70) GPR17FBP1GRIN1
SCHEMBL9740348 0.73 GRIN1 (0.81) GPR17FBP1GRIN1
SCHEMBL13956651 0.72 GPR17 (0.76) GPR17FBP1
SCHEMBL28421067 0.71 GPR17 (0.67) GPR17FBP1GRIN1
SCHEMBL9731281 0.70 GRIN1 (0.67) GPR17FBP1GRIN1
SCHEMBL9731831 0.70 GRIN1 (0.80) GPR17FBP1GRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5284862-A Neurodegenerative disorders including cerebrovascular disorders; antagonists for excitatory amino acid receptors WARNER-LAMBERT COMPANY (US) 1994-02-08 US claimed